AU2001275004A1 - Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation - Google Patents
Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiationInfo
- Publication number
- AU2001275004A1 AU2001275004A1 AU2001275004A AU7500401A AU2001275004A1 AU 2001275004 A1 AU2001275004 A1 AU 2001275004A1 AU 2001275004 A AU2001275004 A AU 2001275004A AU 7500401 A AU7500401 A AU 7500401A AU 2001275004 A1 AU2001275004 A1 AU 2001275004A1
- Authority
- AU
- Australia
- Prior art keywords
- exposure
- ultraviolet radiation
- treating skin
- skin injury
- cox2 inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20879800P | 2000-06-01 | 2000-06-01 | |
US60/208,798 | 2000-06-01 | ||
PCT/US2001/017304 WO2001091856A2 (en) | 2000-06-01 | 2001-05-25 | Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001275004A1 true AU2001275004A1 (en) | 2001-12-11 |
Family
ID=22776106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001275004A Abandoned AU2001275004A1 (en) | 2000-06-01 | 2001-05-25 | Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020009421A1 (en) |
AU (1) | AU2001275004A1 (en) |
WO (1) | WO2001091856A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02012879A (en) * | 2000-06-20 | 2004-07-30 | Herbst Arthur L | Cox-2 inhibitors and the prevention of the side effects of radiation therapy. |
US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
ES2214130B1 (en) * | 2003-02-13 | 2005-12-01 | Almirall Prodesfarma, S.A. | 2-3'-BIPIRIDINES. |
ES2213485B1 (en) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | DERIVATIVES OF 2-FENILPIRAN-4-ONA. |
US20040214861A1 (en) * | 2003-03-28 | 2004-10-28 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine |
US20040224940A1 (en) * | 2003-04-22 | 2004-11-11 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damage |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954332A (en) * | 1987-10-22 | 1990-09-04 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
US5686470A (en) * | 1995-02-10 | 1997-11-11 | Weier; Richard M. | 2, 3-substituted pyridines for the treatment of inflammation |
BR9607035A (en) * | 1995-02-13 | 1997-11-04 | Searle & Co | Isoxazois replaced for the treatment of inflammation |
WO1998016227A1 (en) * | 1996-10-15 | 1998-04-23 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
US5972986A (en) * | 1997-10-14 | 1999-10-26 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
CA2348979A1 (en) * | 1998-11-02 | 2000-05-11 | Merck & Co., Inc. | Method of treating migraines and pharmaceutical compositions |
SA99191255B1 (en) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | celecoxib compounds |
EP1637137A3 (en) * | 1999-03-10 | 2006-07-05 | G.D. Searle LLC | Method and composition for administering a cyclooxygenase-2 inhibitor to animals |
-
2001
- 2001-05-25 US US09/866,196 patent/US20020009421A1/en not_active Abandoned
- 2001-05-25 WO PCT/US2001/017304 patent/WO2001091856A2/en active Application Filing
- 2001-05-25 AU AU2001275004A patent/AU2001275004A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001091856A2 (en) | 2001-12-06 |
US20020009421A1 (en) | 2002-01-24 |
WO2001091856A3 (en) | 2002-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL161775A0 (en) | Topical compositions and methods for treatment of adverse effects ofionizing radiation | |
HUP0201393A2 (en) | Use of xenon for treating neurointoxications | |
AU2002245163A1 (en) | Controlled dose delivery of ultraviolet light for treating skin disorders | |
NO20015112D0 (en) | Use of glycosylceramide synthesis inhibitors in therapy | |
AU2003301111A8 (en) | Apparatus for light treatment of acne and other disorders of follicles | |
EP1267798A4 (en) | Treatment of skin damage using polyenylphosphatidylcholine | |
IL149070A0 (en) | Apparatus and method for targeted uv phototherapy of skin disorders | |
HUP0204182A3 (en) | Use of fumaric acid derivatives for treating mitochondrial diseases | |
AU2003278775A8 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
EP1402068A4 (en) | Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto | |
AU5160201A (en) | Compositions comprising natural agents for treatment of cancer | |
AU2003276607A1 (en) | A device for treating human skin by means of radiation | |
PT1282616E (en) | DERIVATIVES OF HYDROXYPHENYL-PIPERIDIN-4-ILIDENE-METHYL-BENZAMIDE FOR TREATMENT | |
EP1379242A4 (en) | Method for treatment of cancer and compositions for use therein | |
AU2003274590A1 (en) | Device for treating human skin by means of radiation | |
AU2001268233A1 (en) | Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 | |
EP1359885A4 (en) | Nos inhibitors for treatment of wrinkles | |
AU2001275004A1 (en) | Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation | |
IL129705A (en) | Use of selected benzotriazole derivatives for protecting human and animal skin and hair from the harmful effects of uv radiation | |
HUP0302430A3 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience | |
HRP20020729A2 (en) | Treatment of psoriasis | |
AU2003251407A8 (en) | Topical treatment for skin irritation | |
AU2003241346A8 (en) | Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer | |
IL154354A0 (en) | Composition for prophylaxis and treatment of cancer | |
HUP0303268A3 (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |